R E Gregory

555 total citations
9 papers, 438 citations indexed

About

R E Gregory is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, R E Gregory has authored 9 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in R E Gregory's work include Acute Lymphoblastic Leukemia research (2 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Cancer Treatment and Pharmacology (2 papers). R E Gregory is often cited by papers focused on Acute Lymphoblastic Leukemia research (2 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Cancer Treatment and Pharmacology (2 papers). R E Gregory collaborates with scholars based in United States and Australia. R E Gregory's co-authors include David S. Ettinger, Joy Fisher, Fred H. Hochberg, Steven Piantadosi, Lyndon Kim, Stuart A. Grossman, Louise B. Grochow, Edward H. Kovnar, Albert P. Li and Paul O. Zamora and has published in prestigious journals such as Journal of Clinical Oncology, Drugs and Academic Medicine.

In The Last Decade

R E Gregory

9 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R E Gregory United States	8	162	98	88	70	60	9	438
Li Ren China	14	120 0.7×	75 0.8×	273 3.1×	28 0.4×	45 0.8×	46	616
Ebru Ofluoğlu Türkiye	15	177 1.1×	78 0.8×	94 1.1×	95 1.4×	14 0.2×	23	526
Chiara Ticozzi Italy	8	96 0.6×	99 1.0×	91 1.0×	109 1.6×	60 1.0×	9	349
U. Cordes Germany	9	95 0.6×	51 0.5×	93 1.1×	36 0.5×	15 0.3×	54	491
Haiyan Zhou China	10	101 0.6×	44 0.4×	45 0.5×	42 0.6×	38 0.6×	34	317
Maxwell Elia United States	7	39 0.2×	51 0.5×	81 0.9×	158 2.3×	16 0.3×	13	671
Ming-Kuen Lai Taiwan	10	94 0.6×	35 0.4×	150 1.7×	52 0.7×	13 0.2×	11	533
T. Wagner Germany	12	64 0.4×	46 0.5×	51 0.6×	65 0.9×	8 0.1×	43	351
M. Dekock United States	6	45 0.3×	30 0.3×	54 0.6×	95 1.4×	17 0.3×	7	484
Fangfang Zhang China	14	96 0.6×	92 0.9×	55 0.6×	20 0.3×	6 0.1×	33	522

Countries citing papers authored by R E Gregory

Since Specialization

Citations

This map shows the geographic impact of R E Gregory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R E Gregory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R E Gregory more than expected).

Fields of papers citing papers by R E Gregory

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R E Gregory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R E Gregory. The network helps show where R E Gregory may publish in the future.

Co-authorship network of co-authors of R E Gregory

This figure shows the co-authorship network connecting the top 25 collaborators of R E Gregory. A scholar is included among the top collaborators of R E Gregory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R E Gregory. R E Gregory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Downey, Luke A., James Kean, Angela Lau, et al.. (2012). An Acute, Double‐Blind, Placebo‐Controlled Crossover Study of 320 mg and 640 mg Doses of a Special Extract of Bacopa monnieri (CDRI 08) on Sustained Cognitive Performance. Phytotherapy Research. 27(9). 1407–1413. 42 indexed citations

2.

Nolan, Marie T., et al.. (1999). Consent documents, reproductive issues, and the inclusion of women in clinical trials. Academic Medicine. 74(3). 275–81. 7 indexed citations

3.

Grossman, Stuart A., Fred H. Hochberg, Joy Fisher, et al.. (1998). Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. Cancer Chemotherapy and Pharmacology. 42(2). 118–126. 70 indexed citations

4.

Gregory, R E & David S. Ettinger. (1998). 5-HT3 Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting. Drugs. 55(2). 173–189. 220 indexed citations

5.

Mozdziak, Paul, et al.. (1994). Quantitation of Satellite Cell Proliferation in Vivo Using Image Analysis. Biotechnic & Histochemistry. 69(5). 249–252. 7 indexed citations

6.

Gregory, R E, et al.. (1993). Paclitaxel: A New Antineoplastic Agent for Refractory Ovarian Cancer. American Journal of Health-System Pharmacy. 50(7). 1491–1497. 57 indexed citations

7.

Gregory, R E, Ching‐Hon Pui, & W R Crom. (1991). Raised plasma methotrexate concentrations following intrathecal administration in children with renal dysfunction.. PubMed. 5(11). 999–1003. 8 indexed citations

8.

Strother, Douglas, et al.. (1989). Variability in the disposition of intraventricular methotrexate: a proposal for rational dosing.. Journal of Clinical Oncology. 7(11). 1741–1747. 15 indexed citations

9.

Zamora, Paul O., R E Gregory, Albert P. Li, & Antone L. Brooks. (1987). An in vitro model for the exposure of lung alveolar epithelial cells to toxic gases.. PubMed. 7(1-2). 159–68. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact